LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025
LAVA Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 4.99 | 11.98 | 6.77 | 19.39 | 5.35 | 3.75 |
Revenue Growth | -32.06% | 77.01% | -65.09% | 262.45% | 42.78% | - |
Gross Profit Gross Profit Growth | 4.99 | 11.98 | 3.29 | 19.39 | 5.35 | -11.95 |
Operating Income Operating Income Growth | -21.55 | -25.79 | -43.39 | -34.84 | -43.61 | -14.67 |
Net Income Net Income Growth | -23.18 | -25.11 | -41.87 | -31.91 | -42.36 | -15.93 |
Earnings Per Share EPS Growth | -0.86 | -0.94 | -1.57 | -1.23 | -2.14 | -39.90 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 49.66 | 76.58 | 95.57 | 132.87 | 133.2 | 15.82 |
Total Debt Total Debt Growth | - | 5.28 | 6.11 | 5.45 | 4.87 | 4.08 |
Net Cash (Debt) Net Cash Growth | 49.66 | 71.3 | 89.46 | 127.42 | 128.34 | 11.74 |
Net Cash Growth | -31.59% | -20.30% | -29.79% | -0.72% | 993.54% | 110.59% |
Net Cash Per Share Net Cash Per Share Growth | 1.85 | 2.66 | 3.35 | 4.92 | 6.50 | 29.40 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -30.76 | -19.54 | -40.28 | 4.04 | -28.65 | -9.31 |
Capital Expenditures CapEx Growth | - | -0.02 | -0.73 | -0.59 | -0.76 | -0.5 |
Free Cash Flow Free Cash Flow Growth | -30.76 | -19.57 | -41.01 | 3.46 | -29.41 | -9.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 100.00% | 100.00% | 48.56% | 100.00% | 100.00% | - |
Operating Margin | -431.92% | -215.26% | -641.07% | -179.66% | -815.20% | -391.59% |
Pretax Margin | -450.90% | -204.34% | -614.77% | -163.26% | -788.75% | -423.91% |
Profit Margin | -464.59% | -209.60% | -618.57% | -164.55% | -791.68% | -425.06% |
FCF Margin | -616.35% | -163.30% | -605.91% | 17.82% | -549.74% | -261.78% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
P/FCF Ratio | - | - | - | 26.62 | - | - |
PS Ratio | 9.38 | 2.09 | 6.14 | 4.75 | 26.50 | - |